Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1986612
Title:
Composition stabilisée de glucocerebrosidase
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
077635993
WO application number:
US2007061657
Type:
European patent granted for BE
Status:
Open
Publication number:
1986612
WO publication number:
WO 2007/092829
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
06/02/2007
Grant date:
12/09/2012
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
29/11/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
12/09/2012
EP B1 publication date:
12/09/2012
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
06/02/2027
Applicant
1
Name:
Takeda Pharmaceutical Company Limited
Legal Form:
From:
26/09/2023
Address:
1-1, Doshomachi 4-chome,
Chuo-ku, Osaka-shi, Osaka , Japan (JP)
To:
2
Name:
SHIRE HUMAN GENETIC THERAPIES, INC.
Legal Form:
From:
12/09/2012
Address:
300 Shire Way, Lexington MA 02421, United States (US)
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws
2
Bulletin heading:
CO
Journal edition number:
2023/19
Publication date:
19/10/2023
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders